TORCH Panel Rapid Test
Enabling prenatal management at the point of care
TORCH SCREENING
TORCH screening aims to control transmission of TORCH pathogens and assist doctors in Toxo
initiating proper action, in particular to pregnant woman, as severe fetal damage and other 15-75%
serious complications can occur to newborns.
HSV-2 Rubella
9-38% 89-94%
TORCH panel test is designed for pregnant women and women who are planning to
become pregnant
. .
Before pregnancy: During pregnancy:
. .
Planning vaccination for rubella HSV-1 CMV
Eliminating pathogen exposure 40-83%
49-93%
. Proper arrangement of pet care Close monitoring of pregnancy
.
Safe sexual conduct
.
Close monitoring of fetal development
Proper delivery and neonatal strategy
Global seroprevalence of TORCH
in childbearing women
UNIQUE FEATURES OF TORCH PANEL RAPID TEST BY CTK
. Multiplex POCT design
- 5 tests in 1 panel
- 1 test procedure for 10 + 1 parameter results
- detection and differentiation of both IgM and IgG in all 5 tests
. Differentiate HSV-1 and HSV-2
- HSV-1 has been linked to Alzheimer’s, HSV-2 infection increases risk of contracting HIV
- Utilizes recombinant HSV-specific glycoprotein G1 and G2, as recommended by US CDC
. Semi-quantitative results for Rubella
Aids in diagnosis of all 4 infection status
- no immunity - early infection
- active infection - protective immunity
. Whole blood compatible
Allows for testing in various settings, such as
- emergency
- physician office without centrifuge 10-15 minutes
- remote area without skilled lab technicians and stable electricity
No infection Current infection Recent infection Past/Chronic infection
Negative IgM Positive IgM & IgG Positive IgG Positive
TOXO Rubella CMV HSV-1 HSV-2 TOXO Rubella CMV HSV-1 HSV-2 TOXO Rubella CMV HSV-1 HSV-2 TOXO Rubella CMV HSV-1 HSV-2
IgG/IgM IgG/IgM IgG/IgM IgG/IgM IgG/IgM IgG/IgM IgG/IgM IgG/IgM IgG/IgM IgG/IgM IgG/IgM IgG/IgM IgG/IgM IgG/IgM IgG/IgM IgG/IgM IgG/IgM IgG/IgM IgG/IgM IgG/IgM
C C C C C C
C C C C C C C C C C
G M M M M C C C C
M G M M M M M
G1 G M M M M
M G G G G1 G1 G M M
G2 M G2 G G G M G G G G1
G2 M G2 G G G
ID ID ID ID ID ID ID ID
ID ID ID ID ID ID ID ID ID ID ID ID
S S S S S S S S
S S S S S S S S S S S S
Protective immunity
TM
REGISTERED
RAPID TEST PRODUCTS
FACILITY
STRATEGIC PARTNER
TM
RAPID TEST PRODUCTS STRATEGIC PARTNER
OnSite ToRCH Panel & Individual Tests
TORCH PANEL TORCH Panel Rapid Test NEW TOXO Toxo IgG/IgM Rapid Test
T R0253C Serum/Plasma/Whole blood To R0234C Serum/Plasma/Whole blood
IgG OXO
Ig
/Ig
M G/ xo
Ig
The most straight forward TORCH serology test High risk to fetus when infected during or just
Ru
IgG bell
/Ig a
M
M
C
on the market before pregnancy
C
G IgG MV
M /Ig
M
ID C
H C
Simple procedure to achieve comparable
M
G1 IgG SV-1
/Ig
ID
G2
C
M G
H
M
performance against leading ELISA kit as well
M IgG SV-2
S G /Ig
M
ID C
as WHO calibrator
M
S
ID
G
ID
M
C
S
S G
ID
SEMI-QUANTITATIVE
RUBELLA Rubella IgG/IgM Rapid Test CMV CMV IgG/IgM Rapid Test NEW
Ru R0243C Serum/Plasma/Whole blood CM R0224C Serum/Plasma/Whole blood
Ig bel Ig
G/ la G/ V
Ig Ig
M Rubella can be prevented by vaccination. IgG M High risk of congenital infection when newly
C
titer above 15 IU/mL in blood indicates protec- infected during the first half of pregnancy,
C
G1
M tive immunity M usually in the first trimester
G2 G
ID ID
S S
B B
HSV-1 HSV-1 IgG/IgM Rapid Test CE HSV-2 HSV-2 IgG/IgM Rapid Test CE
H R0203C Serum/Plasma/Whole blood H R0213C Serum/Plasma/Whole blood
Ig SV- Ig SV-
G/ 1 G/ 2
Ig Ig
M HSV-1 in babies can cause low birth weight, M HSV-2 is the most common herpes
miscarriage, and preterm birth infection in newborn babies. In addition,
C C
M M HSV-2 infection increases the risk of
G G
contracting HIV
ID ID
S S
B B
CLINICAL PERFORMANCE
Comparable performances against leading ELISA kits
IgM IgG
Pathogen Overall agreement Reference Overall agreement Reference
Toxo 97.8% Diapro 94.9% Diapro
Rubella 96.0% Abbott EIA 97.7% Diapro
CMV 93.9% Diapro 93.4% Diapro
HSV-1 85.0% Diapro 90.7% Diapro
HSV-2 95.2% Trinity Biotech 95.3% Diapro
American Technology | For India
www.athenesedx.com | info@athenesedx.com | +91-44-22541131
Module No. 407 & 408, 4th Floor, TICEL Bio Park II, No. 5, CSIR Road
Taramani, Chennai - 600113, INDIA
